TIAA CREF Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $473K | Sell |
85,036
-52,231
| -38% | -$291K | ﹤0.01% | 2620 |
|
2018
Q4 | $911K | Sell |
137,267
-26,100
| -16% | -$173K | ﹤0.01% | 2322 |
|
2018
Q3 | $1.74M | Buy |
163,367
+28,355
| +21% | +$303K | ﹤0.01% | 2192 |
|
2018
Q2 | $1.62M | Buy |
135,012
+34,636
| +35% | +$416K | ﹤0.01% | 2284 |
|
2018
Q1 | $860K | Hold |
100,376
| – | – | ﹤0.01% | 2511 |
|
2017
Q4 | $992K | Sell |
100,376
-16,025
| -14% | -$158K | ﹤0.01% | 2466 |
|
2017
Q3 | $1.43M | Buy |
116,401
+1,041
| +0.9% | +$12.8K | ﹤0.01% | 2340 |
|
2017
Q2 | $1.9M | Sell |
115,360
-38,623
| -25% | -$635K | ﹤0.01% | 2213 |
|
2017
Q1 | $2.21M | Sell |
153,983
-70,665
| -31% | -$1.01M | ﹤0.01% | 2085 |
|
2016
Q4 | $3.11M | Sell |
224,648
-69,950
| -24% | -$967K | ﹤0.01% | 1930 |
|
2016
Q3 | $5.32K | Buy |
294,598
+82,171
| +39% | +$1.49K | ﹤0.01% | 1565 |
|
2016
Q2 | $3.05M | Buy |
212,427
+59,653
| +39% | +$856K | ﹤0.01% | 1865 |
|
2016
Q1 | $1.83M | Sell |
152,774
-10,030
| -6% | -$120K | ﹤0.01% | 2122 |
|
2015
Q4 | $2.17M | Sell |
162,804
-24,984
| -13% | -$333K | ﹤0.01% | 2093 |
|
2015
Q3 | $2.02M | Buy |
187,788
+45,996
| +32% | +$494K | ﹤0.01% | 2133 |
|
2015
Q2 | $1.14M | Buy |
141,792
+19,563
| +16% | +$157K | ﹤0.01% | 2629 |
|
2015
Q1 | $808K | Hold |
122,229
| – | – | ﹤0.01% | 2733 |
|
2014
Q4 | $779K | Sell |
122,229
-1,942
| -2% | -$12.4K | ﹤0.01% | 2795 |
|
2014
Q3 | $1.23M | Sell |
124,171
-2,019
| -2% | -$19.9K | ﹤0.01% | 2523 |
|
2014
Q2 | $1.42M | Sell |
126,190
-3,165
| -2% | -$35.7K | ﹤0.01% | 2504 |
|
2014
Q1 | $1.57M | Sell |
129,355
-2,845
| -2% | -$34.4K | ﹤0.01% | 2377 |
|
2013
Q4 | $1.67M | Hold |
132,200
| – | – | ﹤0.01% | 2356 |
|
2013
Q3 | $2.19M | Sell |
132,200
-1,910
| -1% | -$31.7K | ﹤0.01% | 2142 |
|
2013
Q2 | $2.04M | Buy |
+134,110
| New | +$2.04M | ﹤0.01% | 2151 |
|